ATE232879T1 - Erythromycin-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel - Google Patents
Erythromycin-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittelInfo
- Publication number
- ATE232879T1 ATE232879T1 AT99402783T AT99402783T ATE232879T1 AT E232879 T1 ATE232879 T1 AT E232879T1 AT 99402783 T AT99402783 T AT 99402783T AT 99402783 T AT99402783 T AT 99402783T AT E232879 T1 ATE232879 T1 AT E232879T1
- Authority
- AT
- Austria
- Prior art keywords
- production
- medicinal products
- erythromycin derivatives
- erythromycin
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9814145A FR2785612A1 (fr) | 1998-11-10 | 1998-11-10 | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE232879T1 true ATE232879T1 (de) | 2003-03-15 |
Family
ID=9532584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99402783T ATE232879T1 (de) | 1998-11-10 | 1999-11-09 | Erythromycin-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US6455505B2 (de) |
| EP (1) | EP1016669B1 (de) |
| JP (1) | JP4698783B2 (de) |
| KR (1) | KR100567695B1 (de) |
| CN (2) | CN100351238C (de) |
| AR (1) | AR025814A1 (de) |
| AT (1) | ATE232879T1 (de) |
| AU (1) | AU766138B2 (de) |
| BR (1) | BR9915236A (de) |
| CA (1) | CA2350651C (de) |
| CZ (1) | CZ20011622A3 (de) |
| DE (1) | DE69905447T2 (de) |
| DK (1) | DK1016669T3 (de) |
| EA (1) | EA200100533A1 (de) |
| ES (1) | ES2189365T3 (de) |
| FR (1) | FR2785612A1 (de) |
| HR (1) | HRP20010335B1 (de) |
| HU (1) | HUP0104035A3 (de) |
| IL (2) | IL142996A0 (de) |
| NO (1) | NO20012272L (de) |
| NZ (1) | NZ511609A (de) |
| PL (1) | PL348098A1 (de) |
| PT (1) | PT1016669E (de) |
| SI (1) | SI20640A (de) |
| TR (1) | TR200101286T2 (de) |
| TW (1) | TWI237027B (de) |
| WO (1) | WO2000027857A2 (de) |
| ZA (1) | ZA200103801B (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| OA11753A (en) * | 1999-01-27 | 2005-07-19 | Pfizer Prod Inc | Ketolide antibiotics. |
| AP2001002302A0 (en) | 1999-05-24 | 2001-10-25 | Pfizer Prod Inc | 13-Methyl erythromycin derivatives. |
| DK1167376T3 (da) | 2000-06-30 | 2004-10-25 | Pfizer Prod Inc | Makrolidantibiotika |
| JP2004017020A (ja) * | 2002-06-20 | 2004-01-22 | Sony Corp | コーティング方法および被コーティング粒子 |
| ES2552682T3 (es) | 2003-03-10 | 2015-12-01 | Merck Sharp & Dohme Corp. | Agentes antibacterianos novedosos |
| JP2008508322A (ja) * | 2004-07-28 | 2008-03-21 | ランバクシー ラボラトリーズ リミテッド | 抗菌剤としてのケトライド誘導体 |
| WO2006046112A2 (en) * | 2004-10-25 | 2006-05-04 | Ranbaxy Laboratories Limited | Ketolide derivatives as antibacterial agents |
| EP2214484A4 (de) | 2007-10-25 | 2013-01-02 | Cempra Pharmaceuticals Inc | Verfahren zur herstellung von antibakteriellen makrolid-wirkstoffen |
| EP2358379B1 (de) * | 2008-10-24 | 2015-12-16 | Cempra Pharmaceuticals, Inc. | Bioabwehr mt triazolhaltigen makroliden |
| US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
| US9480679B2 (en) | 2009-09-10 | 2016-11-01 | Cempra Pharmaceuticals, Inc. | Methods for treating malaria, tuberculosis and MAC diseases |
| DK2550286T3 (en) | 2010-03-22 | 2016-02-29 | Cempra Pharmaceuticals Inc | CRYSTALLINE FORMS OF A MACROLID AND APPLICATIONS THEREOF |
| EP2571506B1 (de) | 2010-05-20 | 2017-05-10 | Cempra Pharmaceuticals, Inc. | Verfahren zur herstellung von makroliden und ketoliden sowie zwischenprodukte dafür |
| EP2613630A4 (de) | 2010-09-10 | 2014-01-15 | Cempra Pharmaceuticals Inc | Wasserstoffbindung zur formung von fluorketoliden zur behandlung von krankheiten |
| KR20140139083A (ko) | 2012-03-27 | 2014-12-04 | 셈프라 파마슈티컬스, 인크. | 마크롤라이드계 항생제를 투여하기 위한 비경구 제제 |
| JP6426696B2 (ja) | 2013-03-14 | 2018-11-21 | センプラ ファーマシューティカルズ，インコーポレイテッド | 呼吸器疾患の治療のための方法および製剤 |
| EP2968384A4 (de) | 2013-03-15 | 2017-02-15 | Cempra Pharmaceuticals, Inc. | Konvergente verfahren zur herstellung antibakterieller makrolidmittel |
| CN111825733A (zh) | 2013-04-04 | 2020-10-27 | 哈佛大学的校长及成员们 | 大环内酯及其制备和使用方法 |
| CN106998685A (zh) | 2014-10-08 | 2017-08-01 | 哈佛大学的校长及成员们 | 14‑元酮内酯及其制备和使用方法 |
| CN107530365A (zh) | 2015-03-25 | 2018-01-02 | 哈佛大学的校长及成员们 | 具有修饰的脱氧糖胺糖的大环内酯及其用途 |
| EP3190122A1 (de) * | 2016-01-08 | 2017-07-12 | LEK Pharmaceuticals d.d. | Neuartiger syntheseweg zu solithromycin und reinigung davon |
| CN106432383A (zh) * | 2016-09-14 | 2017-02-22 | 重庆两江药物研发中心有限公司 | 索利霉素及其中间体的制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5671074A (en) * | 1979-11-12 | 1981-06-13 | Takeda Chem Ind Ltd | 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative |
| FR2669337B1 (fr) * | 1990-11-21 | 1995-03-24 | Roussel Uclaf | Nouveaux derives descladinosyles de l'erythromycine, leur procede de preparation et leur application comme medicaments. |
| IL99995A (en) * | 1990-11-21 | 1997-11-20 | Roussel Uclaf | Erythromycin derivatives, their preparation and pharmaceutical compositions containing them |
| US5527780A (en) * | 1992-11-05 | 1996-06-18 | Roussel Uclaf | Erythromycin derivatives |
| FR2697524B1 (fr) * | 1992-11-05 | 1994-12-23 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
| FR2719587B1 (fr) * | 1994-05-03 | 1996-07-12 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
| FR2727969B1 (fr) * | 1994-12-09 | 1997-01-17 | Roussel Uclaf | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
| FR2742757B1 (fr) * | 1995-12-22 | 1998-01-30 | Roussel Uclaf | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
| PL188173B1 (pl) * | 1996-09-04 | 2004-12-31 | Abbott Lab | Pochodne erytromycyny, sposób wytwarzania pochodnych erytromycyny i środek o działaniu przeciwbakteryjnym |
| US6165986A (en) * | 1997-03-10 | 2000-12-26 | Taisho Pharmaceutical Co., Ltd. | Erythromycin a derivatives |
-
1998
- 1998-11-10 FR FR9814145A patent/FR2785612A1/fr active Pending
-
1999
- 1999-11-03 US US09/433,146 patent/US6455505B2/en not_active Expired - Lifetime
- 1999-11-08 TW TW088119491A patent/TWI237027B/zh not_active IP Right Cessation
- 1999-11-09 AT AT99402783T patent/ATE232879T1/de active
- 1999-11-09 CN CNB200510128838XA patent/CN100351238C/zh not_active Expired - Lifetime
- 1999-11-09 SI SI9920091A patent/SI20640A/sl not_active IP Right Cessation
- 1999-11-09 PL PL99348098A patent/PL348098A1/xx not_active Application Discontinuation
- 1999-11-09 EP EP99402783A patent/EP1016669B1/de not_active Expired - Lifetime
- 1999-11-09 ES ES99402783T patent/ES2189365T3/es not_active Expired - Lifetime
- 1999-11-09 NZ NZ511609A patent/NZ511609A/en unknown
- 1999-11-09 WO PCT/FR1999/002718 patent/WO2000027857A2/fr active IP Right Grant
- 1999-11-09 EA EA200100533A patent/EA200100533A1/ru unknown
- 1999-11-09 CN CNB998154393A patent/CN1240708C/zh not_active Expired - Lifetime
- 1999-11-09 KR KR1020017005854A patent/KR100567695B1/ko active IP Right Grant
- 1999-11-09 CZ CZ20011622A patent/CZ20011622A3/cs unknown
- 1999-11-09 HU HU0104035A patent/HUP0104035A3/hu unknown
- 1999-11-09 DK DK99402783T patent/DK1016669T3/da active
- 1999-11-09 TR TR2001/01286T patent/TR200101286T2/xx unknown
- 1999-11-09 IL IL14299699A patent/IL142996A0/xx active IP Right Grant
- 1999-11-09 JP JP31801599A patent/JP4698783B2/ja not_active Expired - Lifetime
- 1999-11-09 AU AU10526/00A patent/AU766138B2/en not_active Expired
- 1999-11-09 CA CA2350651A patent/CA2350651C/fr not_active Expired - Lifetime
- 1999-11-09 DE DE69905447T patent/DE69905447T2/de not_active Expired - Lifetime
- 1999-11-09 BR BR9915236-3A patent/BR9915236A/pt active Search and Examination
- 1999-11-09 PT PT99402783T patent/PT1016669E/pt unknown
- 1999-11-10 AR ARP990105702A patent/AR025814A1/es not_active Application Discontinuation
-
2000
- 2000-12-11 US US09/734,162 patent/US6407257B1/en not_active Expired - Lifetime
-
2001
- 2001-05-06 IL IL142996A patent/IL142996A/en not_active IP Right Cessation
- 2001-05-09 NO NO20012272A patent/NO20012272L/no not_active Application Discontinuation
- 2001-05-10 HR HR990077A patent/HRP20010335B1/xx not_active IP Right Cessation
- 2001-05-10 ZA ZA200103801A patent/ZA200103801B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE302754T1 (de) | Sulfonylcarboxamidderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| ATE232879T1 (de) | Erythromycin-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel | |
| ATE172203T1 (de) | Erythromycinderivate, ihre verfahren zur herstellung und ihre verwendung als arzneimittel | |
| ATE234853T1 (de) | Erythromycin-derivate, verfahren zur herstellung und ihre verwendung als arzneimittel | |
| DE59806467D1 (de) | Benzamidoxim-derivate, zwischenprodukte und verfahren zu deren herstellung und deren verwendung als fungizide | |
| ATE332898T1 (de) | Neue dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel | |
| DE59908522D1 (de) | Benzothiepin-1,1-dioxidderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung | |
| ATE342899T1 (de) | Diphenylazetidinonderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung | |
| DE50114874D1 (de) | Chinazolinderivate, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung | |
| DE59909418D1 (de) | Arylsubstituierte propanolaminderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung | |
| ATE338039T1 (de) | Diphenylazetidinonderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung | |
| ATE370946T1 (de) | 16-halogen-epothilon-derivate, verfahren zu deren herstellung und ihre pharmazeutische verwendung | |
| ATE265424T1 (de) | Acylphenylharnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| DE69922186D1 (de) | 1-(1-subst.-4-piperidinyl)methyl]-4-piperidin-derivate, verafhren zu deren herstellung, pharmazeutische mixturen und intermediate zu deren herstellung | |
| DE69712610D1 (de) | Erythramicin-derivate, ihre verfahren zur herstellung und ihre verwendung als arzneimittel | |
| DE59707976D1 (de) | Neue guanidinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| ATE234842T1 (de) | Epithilonderivate, verfahren zu deren herstellung und deren verwendung | |
| ATE267825T1 (de) | Mit heterocyclen substituierte propanolaminderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung | |
| ATE263144T1 (de) | Neue phenylamidinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| ATE304534T1 (de) | Aminocarbonyl-substituierte benzimidazolderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| ATE301645T1 (de) | Polycyclische thiazolidin-2-yliden amine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| DE59909606D1 (de) | Substituierte 1,3-diaryl-2-pyridin-2-yl-3-(pyridin-2-ylamino)-propanolderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung | |
| ATE267811T1 (de) | Substituierte 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin- 0-ole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| DE69901098D1 (de) | Hypnotische beta-carbolin derivate verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| DE69716284D1 (de) | Erythromycin-derivate, verfahren zur herstellung und verwendung als arzneimittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1016669 Country of ref document: EP |